Figure 2
Mean change in visual acuity from baseline at each time point during the 4-year follow-up period. (A) Total eyes, (B) typical neovascular age-related macular degeneration subgroup, and (C) polypoidal choroidal vasculopathy subgroup.
Figure 2 | Scientific Reports
